Biomarkers of neurological and psychiatric disease. Preface.
出版信息
Int Rev Neurobiol. 2011;101:xv-xx. doi: 10.1016/B978-0-12-387718-5.00022-5.
Abstract
摘要
相似文献
1
Biomarkers of neurological and psychiatric disease. Preface.
Int Rev Neurobiol. 2011;101:xv-xx. doi: 10.1016/B978-0-12-387718-5.00022-5.
2
Discovery and development of biomarkers of neurological disease.
Drug Discov Today. 2005 Mar 1;10(5):326-34. doi: 10.1016/S1359-6446(04)03353-7.
3
Human pharmacological MRI.
Trends Pharmacol Sci. 2004 Jul;25(7):366-74. doi: 10.1016/j.tips.2004.05.009.
4
Neuroimaging distinction between neurological and psychiatric disorders.
Br J Psychiatry. 2015 Nov;207(5):429-34. doi: 10.1192/bjp.bp.114.154393. Epub 2015 Jun 4.
5
Performance monitoring in neurological and psychiatric patients.
Int J Psychophysiol. 2006 Jan;59(1):59-69. doi: 10.1016/j.ijpsycho.2005.06.010. Epub 2005 Nov 8.
6
Granins as disease-biomarkers: translational potential for psychiatric and neurological disorders.
Neuroscience. 2010 Sep 29;170(1):289-97. doi: 10.1016/j.neuroscience.2010.06.057. Epub 2010 Jul 1.
7
Proteomic biomarkers for psychiatric disorders: a progress update.
Biomark Med. 2012 Apr;6(2):189-92. doi: 10.2217/bmm.12.6.
8
Integrating Models of Neurologic and Psychiatric Disease.
JAMA Neurol. 2017 Jul 1;74(7):759-760. doi: 10.1001/jamaneurol.2017.0309.
9
Clinical utility of event-related potentials in neurology and psychiatry.
Semin Neurol. 1990 Jun;10(2):196-203. doi: 10.1055/s-2008-1041269.
10
Preface. Genetics of neurologic and psychiatric diseases.
Clin Lab Med. 2010 Dec;30(4):xiii-xiv. doi: 10.1016/j.cll.2010.07.012.
Zotero 插件